Rr Advisors Position in Genesis Energy LP Houston Com (GEL) Has Lowered as Market Value Rose; Gramercy Funds Management Raised Vale S A (VALE) Stake – MЕSА Wееkly

Rr Advisors Llc decreased its stake in Genesis Energy Lp Houston Com (GEL) by 4.5% based on its latest 2019Q2 regulatory filing with the SEC. Rr Advisors Llc sold 148,000 shares as the company’s stock rose 4.15% . The institutional investor held 3.14M shares of the energy company at the end of 2019Q2, valued at $68.73 million, down from 3.29M at the end of the previous reported quarter. Rr Advisors Llc who had been investing in Genesis Energy Lp Houston Com for a number of months, seems to be less bullish one the $2.65 billion market cap company. The stock increased 0.92% or $0.2 during the last trading session, reaching $21.65. About 215,721 shares traded. Genesis Energy, L.P. (NYSE:GEL) has declined 0.17% since October 22, 2018 and is downtrending. It has underperformed by 0.17% the S&P500. Some Historical GEL News: 22/05/2018 – SHAREHOLDER GENESIS INVESTMENT MANAGEMENT BUYS 5.6 PCT STAKES IN SOK MARKETLER SOKM.IS – KAP; 08/05/2018 – MALLINCKRODT PLC – QTRLY H.P. ACTHAR GEL NET SALES WERE $243.8 MLN, DOWN 10.3% OVER $271.8 MLN DUE TO RESIDUAL IMPACT OF PATIENT WITHDRAWAL ISSUES; 07/05/2018 – MALLINCKRODT: SYNACTHEN TETRACOSACTIDE ISN’T H.P. ACTHAR GEL; 07/05/2018 – Mallinckrodt: Information on H.P. Acthar Gel Posted on Website in Response to ’60 Minutes’ Report; 10/04/2018 – ClinicalTrial US: A Phase I Study of HY209 Gel in Healthy Male Volunteers for Atopic Dermatitis (Shaperon); 02/04/2018 – Sientra Reports the Long-term Safety and Effectiveness of Silicone Gel Breast Implants with Results from the Largest Core Breast Implant Trial To-Date; 22/05/2018 – ASICS Launches The 25th lteration Of The GEL-KAYANO® Series, Helping Runners Go The Distance; 30/05/2018 – EyeGate Files Supplement to Investigational Device Exemption to Commence Study in Punctate Epitheliopathy using the EyeGate Ocular Bandage Gel; 04/04/2018 – Genesis Vision Launches Alpha Version of Asset Management Platform; 18/03/2018 – Canon Medical Systems’ Aquilion ONE / GENESIS Edition Delivers Full Suite of Acute Stroke Solutions

Gramercy Funds Management Llc increased its stake in Vale S A (VALE) by 52.67% based on its latest 2019Q2 regulatory filing with the SEC. Gramercy Funds Management Llc bought 331,640 shares as the company’s stock rose 4.93% . The hedge fund held 961,340 shares of the precious metals company at the end of 2019Q2, valued at $12.92M, up from 629,700 at the end of the previous reported quarter. Gramercy Funds Management Llc who had been investing in Vale S A for a number of months, seems to be bullish on the $59.54 billion market cap company. The stock increased 2.02% or $0.23 during the last trading session, reaching $11.61. About 9.53 million shares traded. Vale S.A. (NYSE:VALE) has declined 8.73% since October 22, 2018 and is downtrending. It has underperformed by 8.73% the S&P500. Some Historical VALE News: 25/04/2018 – BRAZIL’S VALE POSTS FIRST QUARTER ADJUSTED EBITDA OF $3.971 BLN; 16/04/2018 – VALE 1Q IRON-ORE OUTPUT 82M TONS; 14/03/2018 – Vale announces the redemption of its 4.625% guaranteed notes due 2020 and a cash tender offer for its 5.875% guaranteed notes d; 03/04/2018 – VALE TO REPORT 1Q OUTPUT REPORT ON APRIL 16 BF MKT; 14/03/2018 – RPT-COLUMN-China’s iron ore mountain may only be a molehill: Russell; 15/05/2018 – YARA INTL CLOSING OF YARA PURCHASE OF VALE CUBATAO; 25/04/2018 – BRAZIL’S VALE SAYS FIRST-QUARTER INVESTMENTS TOTAL $890 MLN; 29/03/2018 – VALE SAYS BOARD COULD DECIDE TO PAY EXTRAORDINARY DIVIDENDS; 16/04/2018 – VALE 1Q IRON-ORE OUTPUT 82M TONS, EST. 75.4M TONS; 24/05/2018 – Vale sees key mine topping iron ore output forecasts in 2018

Since May 9, 2019, it had 4 insider purchases, and 0 insider sales for $344,270 activity. Flynn Edward T also bought $100,600 worth of Genesis Energy, L.P. (NYSE:GEL) on Monday, August 26. Jesulaitis Kristen O bought $99,850 worth of Genesis Energy, L.P. (NYSE:GEL) on Monday, August 12.

Investors sentiment decreased to 0.89 in 2019 Q2. Its down 0.13, from 1.02 in 2019Q1. It fall, as 12 investors sold GEL shares while 41 reduced holdings. 18 funds opened positions while 29 raised stakes. 84.94 million shares or 3.08% less from 87.65 million shares in 2019Q1 were reported. Barclays Public Ltd Com accumulated 0% or 47,930 shares. 284,426 were reported by State Of New Jersey Common Pension Fund D. Hm Payson accumulated 250 shares. Cv Starr Communications Incorporated reported 2.99% of its portfolio in Genesis Energy, L.P. (NYSE:GEL). Citigroup Inc holds 0% or 168,848 shares in its portfolio. 799,532 were accumulated by Tortoise Advisors Ltd. Mirae Asset Global Invs Ltd stated it has 2.09M shares. Wells Fargo Mn invested in 595,411 shares or 0% of the stock. Harvest Fund Ltd has invested 0.26% in Genesis Energy, L.P. (NYSE:GEL). Salient Cap Advsrs Lc accumulated 4.72M shares. Enterprise Service Corporation, a Missouri-based fund reported 1,517 shares. Stifel Fincl Corp holds 0% or 30,210 shares. Cbre Clarion Secs Ltd Liability Corporation has invested 0.02% in Genesis Energy, L.P. (NYSE:GEL). Raymond James Financial Serv Advsrs Incorporated accumulated 0.02% or 271,413 shares. National Bank Of Montreal Can reported 1.49 million shares.

Analysts await Genesis Energy, L.P. (NYSE:GEL) to report earnings on November, 7. They expect $0.22 earnings per share, up 246.67% or $0.37 from last year’s $-0.15 per share. GEL’s profit will be $26.96 million for 24.60 P/E if the $0.22 EPS becomes a reality. After $0.17 actual earnings per share reported by Genesis Energy, L.P. for the previous quarter, Wall Street now forecasts 29.41% EPS growth.

More notable recent Genesis Energy, L.P. (NYSE:GEL) news were published by: Businesswire.com which released: “Genesis Energy, L.P. Announces Expansion of Existing Sodium Services Operations – Business Wire” on September 23, 2019, also Seekingalpha.com with their article: “Genesis Energy declares common unit distribution of $0.55 – Seeking Alpha” published on April 12, 2019, Bizjournals.com published: “CVS Health steps up safe drug disposal strategy – Boston Business Journal” on October 21, 2019. More interesting news about Genesis Energy, L.P. (NYSE:GEL) were released by: Seekingalpha.com and their article: “Mallinckrodt analysis shows cost-effectiveness of Acthar Gel for late-line MS relapses – Seeking Alpha” published on September 13, 2019 as well as Benzinga.com‘s news article titled: “10 Energy Stocks Moving In Today’s Pre-Market Session – Benzinga” with publication date: July 30, 2019.

Gramercy Funds Management Llc, which manages about $3.11 billion and $195.18M US Long portfolio, decreased its stake in Bausch Health Cos Inc by 14,700 shares to 37,500 shares, valued at $946,000 in 2019Q2, according to the filing. It also reduced its holding in Transocean Ltd (NYSE:RIG) by 175,504 shares in the quarter, leaving it with 607,175 shares, and cut its stake in Ypf Sociedad Anonima (NYSE:YPF).